PLK4 and central nervous system cancer: A previous study by our group demonstrated that PLK4 could enhance the sensitivity to chemotherapy in gliomas by phosphorylating the inhibitor of nuclear factor-kappa B kinase subunit epsilon (IKBKE) (5).